[Type IV anaphylactic reaction and ST-elevation acute coronary syndrome due to coronary vasospasm secondary to administration of cisatracurium].
Benítez Morillo
M F
MF
Casares Vivas
M
M
Tejada Ruiz
F J
FJ
Narváez Bermejo
J M
JM
D054058:Acute Coronary Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced* / Q000145:classification; D001279:Atracurium / Q000009:adverse effects / Q000031:analogs & derivatives*; D003329:Coronary Vasospasm / Q000150:complications*; D005260:Female; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects*
D009466:Neuromuscular Blocking Agents; D001279:Atracurium; C101584:cisatracurium